Search Results - "Krause, F S"

Neuropilin‐2 and its ligand VEGF‐C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients by Keck, B., Wach, S., Taubert, H., Zeiler, S., Ott, O.J., Kunath, F., Hartmann, A., Bertz, S., Weiss, C., Hönscheid, P., Schellenburg, S., Rödel, C., Baretton, G.B., Sauer, R., Fietkau, R., Wullich, B., Krause, F.S., Datta, K., Muders, M.H.

“…The standard treatment for invasive bladder cancer is radical cystectomy. In selected patients, bladder‐sparing therapy can be performed by transurethral…”
Get full text

Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy by Bertz, Simone, Wach, S., Taubert, H., Merten, R., Krause, F. S., Schick, S., Ott, O. J., Weigert, E., Dworak, O., Rödel, C., Fietkau, R., Wullich, B., Keck, B., Hartmann, A.

“…Purpose of this study was to evaluate prognostic impact of rare variants of urothelial bladder cancer (BC) after treatment with combined radiochemotherapy…”
Get full text

Polymorphisms of Human Estrogen Receptor (ER) Gene Alpha and Beta in Prostate Cancer PC-EW and PC-OR Cell Lines by BERGNER, C. C, KRAUSE, F. S, ZUGOR, V, RITH, T, SCHROTT, K. M, ENDELE, S, ENGEHAUSEN, D. G

“…Background: Prostate cancer is the second leading cause of death among men in Western countries. Genetic alterations of the estrogen receptor gene are known to…”
Get full text

Does the Distance to Normal Renal Parenchyma (DTNRP) in Nephron-sparing Surgery for Renal Cell Carcinoma have an Effect on Survival? by AKCETIN, Z, ZUGOR, V, ELSÄSSER, D, KRAUSE, F. S, LAUSEN, B, SCHROTT, K. M, ENGEHAUSEN, D. G

“…Background: The effect of the distance to normal renal parenchyma (DTNRP) on survival after nephron-sparing surgery (NSS) for renal cell cancer (RCC) was…”
Get full text

Radiochemotherapy after Transurethral Resection is an Effective Treatment Method in T1G3 Bladder Cancer by AKCETIN, Z, TODOROV, J, TÜZEL, E, ENGEHAUSEN, D. G, KRAUSE, F. S, SAUER, R, SCHROTT, K. M, RÖDEL, C

“…Aim: Conservative therapy using deep transurethral resection (TUR) followed by radiochemotherapy is a novel treatment strategy in stage TI grade 3 (T1G3)…”
Get full text

Polymorphisms in the Human Progesterone Receptor (PGR) Gene of Two Human Prostate Adenocarcinoma Cell Lines by ENGEHAUSEN, Dirk G, ENDELE, Sabine, KRAUSE, Steffen F, RITH, Torsten, SCHROTT, Karl M, AKCETIN, Ziya

“…Background: The incidence and mortality rate of prostate cancer has been steadily increasing in most countries worldwide. A potential implication of the…”
Get full text

Polymorphisms of Human Androgen Receptor (hAR) Gene in Prostate Cancer Cell Lines PC-EW and PC-OR by ENGEHAUSEN, Dirk G, KRAUSE, F. Steffen, FLEISCHMANN, Johann, AKCETIN, Ziya, SCHROTT, Karl M, ENDELE, Sabine

“…Background: Prostate cancer is the leading tumor of the male in Western societies. Genetic alterations of the androgen receptor gene are known in the advanced…”
Get full text

The photodynamic diagnosis (PDD) for early detection of carcinoma and dysplasia of the bladder by Zumbraegel, A, Bichler, K H, Krause, F S, Feil, G, Nelde, H J

Get more information

Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer by Krause, F S, Feil, G, Bichler, K H

“…Bladder cancer is clinically characterized by a high recurrence rate for superficial tumours up to 70% and by the invasiveness of advanced bladder cancer. To…”
Get more information

Molecular genetic methods in the diagnosis of invasive bladder cancer by Krause, F S, Feil, G, Zumbrägel, A, Bichler, K H

“…Development and progression of tumours is generally driven by an accumulation of genetic alterations. In this study we correlated chromosome 17 aneuploidy to…”
Get more information

B-cell lymphoma of the testes by Zugor, V, Frank, M, Krause, F S, Schott, G E, Aigner, T, Engehausen, D G

“…The occurrence of primary non-Hodgkin's lymphomas of the testes is described in just a few studies in the urological literature. The clinical symptomatology…”
Get full text

Value of radical oncological surgery in bilateral synchronous renal cell cancer and coincidental simultaneous prostate cancer by Rud, Oleg, Krause, F S, Engehausen, D G, May, M, Gilfrich, C

“…To date, the current literature does not report on oncological surgery in bilateral renal cell cancer and coincidental simultaneous prostate cancer. We present…”
Get more information

Heterogeneity in Prostate Cancer: Prostate Specific Antigen (PSA) and DNA Cytophotometry by KRAUSE, F. Steffen, FEIL, Gerhard, BICHLER, Karl-Horst, SCHROTT, Karl M, AKCETIN, Ziya Y, ENGEHAUSEN, Dirk G

“…Background: The heterogeneity in prostate cancer is the reason for the difficult diagnosis and prognosis of this tumor. In this study, we looked for a…”
Get full text

Bilateral renal oncocytoma by Moisin, L, Krause, F S

Get more information

B-Zell-Lymphome des Hodens by Zugor, V, Frank, M, Krause, F S, Schott, G E, Aigner, T, Engehausen, D G

“…Das Auftreten von primären Non-Hodgkin-Lymphomen (NHL) des Hodens ist in der urologischen Literatur in wenigen Studien beschrieben. Dabei werden die klinische…”
Get full text

Detection of HER-2/neu CEP 17 mutations at invasive bladder cancer by Feil, Gerhard, Krause, F Steffen, Zumbraegel, Andreas, Bichler, Karl H

Get more information

Ki67, p53, nm23, and DNA cytometry in bladder cancer: potential markers for detection of recurrence? by Feil, Gerhard, Krause, F Steffen, Zumbraegel, Andreas, Wechsel, Hans W, Bichler, Karl H

Get more information

Clinical aspects for the use of DNA image cytometry in detection of bladder cancer: a valuable tool? by Krause, F Steffen, Feil, Gerhard, Bichler, Karl-H, Schrott, Karl M, Akcetin, Ziya Y

“…The employment of DNA flow or image cytometry for oncological diagnostic procedures is favored because of its high correlation to tumor biological behavior…”
Get more information

B-Zell-Lymphome des Hodens by Zugor, V., Frank, M., Krause, F. S., Schott, G. E., Aigner, T., Engehausen, D. G.

Get full text

DNA cytophotometry in renal cell carcinoma: a significant prognostic factor? by Feil, G, Mittermüller, B, Bichler, K H, Wunderer, A, Wechsel, H W, Nelde, H J, St Krause, F

“…We report on a prospective DNA cytophotometric study of 66 patients with renal tumors, 61 of whom had renal cell carcinoma (RCC) (pT1-pT4, G1-G3). 16 of the…”
Get more information